NR4A1 and type 2 diabetes mellitus: Premenopausal breast cancers in type 2 diabetics are often aggressive and hormone-receptor-negative, whereas postmenopausal cases are commonly hormone-receptor-positive and influenced by adipose-derived estrogen.